AGC Biologics Appoints Jean-Baptiste Agnus as Chief Business Officer
November 01, 2021 09:03 ET | AGC Biologics
Seattle, Nov. 01, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced Jean-Baptiste Agnus has been...
Cytovance_HepaLink_Digtial_032017.jpg
Cytovance Biologics announces Plasmid DNA Manufacturing: An Optimized Platform Process Webinar
June 14, 2021 03:00 ET | Cytovance Biologics
OKLAHOMA CITY, June 14, 2021 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial and gene therapy...
AGC Biologics’ Heidelberg Facility to Further Supply Plasmid DNA for COVID-19 Vaccine
June 07, 2021 10:06 ET | AGC Biologics
Seattle, June 07, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced its partnership with BioNTech...
Cytovance_HepaLink_Digtial_032017.jpg
Cytovance Biologics now offering Licensing for Plasmid DNA Manufacturing
March 08, 2021 03:00 ET | Cytovance Biologics
OKLAHOMA CITY, March 08, 2021 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial biologics and...
Cytovance_HepaLink_Digtial_032017.jpg
Cytovance Biologics offers Nature Technology Corporation’s proprietary HyperGRO™ manufacturing platform for plasmid DNA CGMP manufacturing
November 30, 2020 03:00 ET | Cytovance Biologics
OKLAHOMA CITY, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial biologics and...
Cytovance Biologics Announces Bin Zhang as Chief Executive Officer
November 09, 2020 03:00 ET | Cytovance Biologics
OKLAHOMA CITY, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian and microbial biologics,...
Cytovance_HepaLink_Digtial_032017.jpg
Cytovance Biologics Announces an Investment in Mass Spectrometry Services
July 15, 2020 03:00 ET | Cytovance Biologics
OKLAHOMA CITY, July 15, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces the addition of Mass...
Cytovance_HepaLink_Digtial_032017.jpg
Cytovance Biologics Promotes John Mott to Vice President of Development
July 13, 2020 03:00 ET | Cytovance Biologics
OKLAHOMA CITY, July 13, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces the promotion of Dr. John...
Aldevron, Nature Technology Corporation team up to offer Nanoplasmids™ for gene therapy manufacturing
October 22, 2019 07:00 ET | Aldevron
Fargo, N.D, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Aldevron has announced the immediate availability of Nanoplasmids™ and antibiotic-free RNA-OUT technology for use in gene therapy manufacturing. Through...
Aldevron, Nature Technology Corporation team up to offer Nanoplasmids™ for gene therapy manufacturing
October 22, 2019 01:00 ET | Aldevron
Fargo, N.D., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Aldevron has announced the immediate availability of Nanoplasmids™ and antibiotic-free RNA-OUT technology for use in gene therapy manufacturing....